Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brent Rosser

Pediatrics Murfreesboro, TN Medical Doctor

NPI 1285787036 CMS profile 1112615

1272 Garrison Dr, Murfreesboro, TN 37129

Open in the dashboard

General payments

$4,028

300 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brent Rosser of Murfreesboro, TN is reported in the CMS Open Payments database as having received $4,028 across 300 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $315 33
2024 General $543 45
2023 General $732 53
2022 General $1,290 89
2021 General $522 37
2020 General $247 17
2019 General $378 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brent Rosser
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Brent Rosser were reported at $315. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Brent Rosser Pediatrics median Middle half National median
2019 $378 $86 $31–$183 $163
2020 $247 $49 $22–$110 $114
2021 $522 $68 $27–$158 $132
2022 $1,290 $77 $30–$173 $149
2023 $732 $88 $33–$190 $160
2024 $543 $94 $34–$206 $164
2025 $315 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $1,882 168 payments
  2. Corium, Inc. $369 21 payments
  3. GlaxoSmithKline, LLC. $316 19 payments
  4. Tris Pharma Inc $278 19 payments
  5. Pfizer Inc. $216 14 payments
  6. Neos Therapeutics, LP $134 8 payments
  7. Ironshore Pharmaceuticals Inc. $116 8 payments
  8. kaleo, Inc. $113 8 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $92 6 payments
  10. Sobi, Inc $86 5 payments
  11. Other $426 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,021 299 payments
  2. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. QELBREE Psychology $1,121 95 payments
  2. Qelbree Viloxazine Hydrochloride $751 72 payments
  3. Azstarys $369 21 payments
  4. BEXSERO $302 18 payments
  5. Dyanavel XR $151 11 payments
  6. PEDIARIX $145 10 payments
  7. COMIRNATY $139 8 payments
  8. COTEMPLA XR-ODT $134 8 payments
  9. TRUMENBA $120 7 payments
  10. Adzenys XR-ODT $118 7 payments
  11. Other $1,274 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

300 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record